• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Patents Without Examination: A Bad Solution For The 21st Century

30/04/2018 by Intellectual Property Watch 7 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

The views expressed in this article are solely those of the authors and are not associated with Intellectual Property Watch. IP-Watch expressly disclaims and refuses any responsibility or liability for the content, style or form of any posts made to this forum, which remain solely the responsibility of their authors.

[Editor’s Note: a Portuguese translation of this article appears on IP-Watch here.]

By Arjun Jayadev and Dean Baker

Brazil has historically been at the forefront of developing countries pushing for a more balanced intellectual property (IP) regime.

Over the past two decades, there has been serious pushback from the developing world against the dominant IP regime. In large part, this is because wealthier countries have sought to impose a one-size-fits-all model on the world, by influencing the rule-making process at the World Trade Organization (WTO) and forcing their will via trade agreements.

Temer’s presidency and its right-wing policies have been met with massive protests in Brazil.

The IP standards advanced countries favour typically are designed not to maximise innovation and scientific progress, but to maximise the profits of big companies able to sway trade negotiations. No surprise, then, that large developing countries with substantial industrial bases – such as South Africa, India and Brazil – have been leading the counterattack.

These countries are fully justified in opposing an IP regime that is neither equitable nor efficient. In a recent paper, for a Shuttleworth Foundation project on access to medicines, and published by Fiocruz in Rio de Janeiro, we review the arguments about the role of intellectual property in the process of development. We show that the preponderance of theoretical and empirical evidence indicates that the economic institutions and laws protecting knowledge in today’s advanced economies are increasingly inadequate to govern global economic activity, and are poorly suited to meet the needs of developing countries and emerging markets.

Even in the United States and other advanced industrialised countries, the patent system is in a period of crisis. There is widespread concern over the proliferation of bad patents — those that are not real advances on existing knowledge. Bad patents can provide an impediment to follow-on innovation, while providing at best weak incentives for innovative activities themselves.

In fields such as information technology, a whole set of bad patents and an epidemic of over-patenting has made subsequent innovation difficult, and has eroded some of the gains from knowledge creation. There is a shrinking of the knowledge commons as even publicly funded and promoted innovation is privatised, thereby reducing both equity and efficiency. There is no agreement on what exactly ought to be done, but it is certainly recognised that the current system is not satisfactory for developed countries.

The central problem is that knowledge is a (global) public good, both in the technical sense that the marginal cost of someone using it is zero and in the more general sense that an increase in knowledge can improve wellbeing globally. Given this, the worry has been that the market will undersupply knowledge and research will not be adequately incentivised.

Throughout the late 20th century, the conventional wisdom was that this market failure could best be rectified by introducing another one: private monopolies, created through stringent patents, strictly enforced. But private IP protection is just one route to solving the problem of encouraging and financing research. It has been more problematic than had been anticipated, even for advanced countries.

An increasingly dense “patent thicket” in a world of products requiring thousands of patents has sometimes stifled innovation, with more spent on lawyers than on researchers in some cases. Research is often directed not at producing new products but at extending, broadening and leveraging the monopoly power granted through the patent.

We recognize that Brazil has a serious problem with a large backlog of patents, but the proposed solution of approving patents without a substantive examination is inviting disaster. While many of the pending patents are surely deserving of approval, it is undoubtedly the case that many are not.

In some cases, people will have filed for patents that overlap with existing patents. This will be an invitation for a large number of lawsuits, as owners of conflicting claims will fight over royalties.

In the same vein, many of the pending patents are almost frivolous. There is a long history of people attempting to patent processes or products that are completely obvious and involve no innovation whatsoever. For example, Amazon attempted to patent the use of one-click shopping online. Granting frivolous patents will both drastically raise costs for Brazilian consumers, as they will then have to pay patent fees for items that should be free, as well as impede further innovation since many areas for research will be far more costly as a result of wrongly granted patents.

The result of this wholesale granting of patents will be to simply move the backlog at the patent office to the legal system, as it virtually guarantees a flood of lawsuits that Brazil’s courts will be unable to deal with.

The current backlog in Brazil is problematic. Pending patent applications can also be harmful for innovation, for competition, and for access to the fruits of innovation. However, the proposed “solution” is not the way to go. It is against Brazil’s historical position to fight for a better balance between public and private and developed and developing countries in the IP system. It is also against theoretical and empirical evidence that shows a more open system could encourage the diffusion of knowledge, leading to economic growth – and thus to gains in human development and welfare. And it is in the opposite direction of what is being done by other emerging economies.

South Africa, for instance, after decades of implementing a non-examination system for the granting of patents, in which the claims only get interrogated if a third party challenged them, is now implementing a major policy shift whose main goal is to end the depository patent system.

An IP regime dictated by the advanced countries more than a quarter of a century ago, in response to political pressure by a few of their most powerful corporations, makes little sense in today’s world. Maximising profits for a few, rather than global development and welfare for many, did not make much sense then, either – but it happened anyway, due to the power dynamics at the time.

Those dynamics are finally changing, and emerging economies are taking the lead in creating a balanced IP system that recognises the importance of knowledge for development, growth and wellbeing. What matters is not only the production of knowledge, but also that it is used in ways that put people’s health and welfare before corporate profits.

Brazil has historically taken good decisions toward that goal. The automatic granting of patents without a substantive examination would send the country backwards.

Arjun Jayadev is Professor of Economics at Azim Premji University in Bangalore and a senior economist at the Institute for New Economic Thinking.

Dean Baker is senior economist at the Center for Economic and Policy Research in Washington, DC. He is frequently cited in economics reporting in major media outlets, including the New York Times, Washington Post, CNN, CNBC, and National Public Radio.

 

Image Credits: By AmandaLemosNeuroMat [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], from Wikimedia Commons, By Rovena Rosa/Agência Brasil [CC BY 3.0 br (https://creativecommons.org/licenses/by/3.0/br/deed.en)], via Wikimedia Commons

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Creative Commons License"Patents Without Examination: A Bad Solution For The 21st Century" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Development, English, Health & IP, Health Policy Watch, Latin America/Caribbean, Patents/Designs/Trade Secrets, Regional Policy

Comments

  1. Bojan Pretnar says

    30/04/2018 at 5:12 pm

    There is a good and well-proven solution, which makes possible to have examined patents without examination, and thus it could be of interest for Brazil. The unusual though in principle simple solution was developed by Dr. Bojan Pretnar in his capacity as the first Director of Slovenian IP Office, which was established literary from scratch after Slovenia declared its independence in 1991. The solution was highly praised by A. Bogsch, the legendary Director General of WIPO, by AIPPI at its 1992 Congress in Tokio, and in academic literature (IIC, GRUR). In 1993, the said solution opened the door for signing the very first “Extension Agreement” between Slovenia and EPO.The solution has been since then encoded in Slovenian Industrial Property Act, which is available in English at official website of Slovenian IP Office http://www.uil-sipo.si .

    Reply
  2. Nuno Pires de Carvalho says

    30/04/2018 at 7:12 pm

    Unfortunately, both commentators are not familiar with the experience of Brazilian patent law. The same approach of simplified patent granting was adopted some 15 years ago. The backlog then existing disappeared and there was no significant increase in litigation. Actually, the feared deluge of litigation has been taking place in the last four, five years, with patent applicants resorting massively to federal courts so as to compel the patent office to issue the examination report in 60 days. Not only this practice has sunk the Federal court in Rio de Janeiro (2nd Federal Region) with useless litigation, but also it sets a discriminatory practice, because only those that can afford litigation can take advantage of that 60 day period (a provision of administrative law). Eventually, the simplified procedure that the Federal Government is about to approve may not be as good as speedy and accurate examination, but it is better than the current backlog — which, among other negative impacts, has scared away Brazilian inventors and small companies from filing patent applications

    Reply
  3. Oscar Lizarazo says

    05/05/2018 at 12:26 pm

    In theory, the proposal excludes pharmaceutical patents in the strict sense. But it does not exclude general patent applications in biotechnology. There are several pending patent applications about genetic editing tools such as CRISPR Cas9 and its variants. This could affect Brazil, not only in matters of human health, but also in animal health, agriculture, industrial biotechnology, etc.

    Reply
  4. Oscar Lizarazo says

    05/05/2018 at 12:46 pm

    Undoubtedly, the commentator is more familiar with the practice of patents in Brazil.
    But, biases?
    – http://lickslegal.com/client-alerts/nuno-pires-de-carvalho-joins-licks-attorneys/

    – https://www.chambersandpartners.com/Latin-America/department/12731

    Are there any possible advantages derived from the backlog, and from the restrictive patent criteria in Brazil?
    For example: Greater freedom to operate, which allowed national companies on pharmaceutical, agricultural biotechnology, software, industry to strengthen?

    Reply

Trackbacks

  1. Patentes Sem A Realização De Análise Técnica: Uma Péssima Solução Para O Século 21 - Intellectual Property Watch says:
    30/04/2018 at 10:31 pm

    […] [Editor’s note: An English language version of this article appears on IP-Watch here.] […]

    Reply
  2. Patentes Sem A Realização De Análise Técnica: Uma Péssima Solução Para O Século 21 says:
    05/05/2018 at 5:12 pm

    […] [Editor’s note: An English language version of this article appears on IP-Watch here.] […]

    Reply
  3. Patentes Sem A Realização De Análise Técnica: Uma Péssima Solução Para O Século 21 – Health Policy Watch says:
    05/09/2018 at 10:50 pm

    […] [Editor’s note: An English language version of this article appears on IP-Watch here.] […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Top Global Health stories

New WHO Director Tedros’s Opening Vision: People First

Enter The African Medicines Agency, Continent’s First Super-Regulator?

More health stories...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.